One day after hitting the ‘all-time low’, India’s daily Covid-19 count drops further to 29,163
India registered 29,163 new cases of the coronavirus disease (Covid-19) on Tuesday. The nationwide count is now 88,74,290, according to the Union Health Ministry update at 8 a.m.
The number of active cases remains below the five lakh mark and the number of discharged patients has reached 82,90,370.
The country recorded 449 new deaths due to Covid-19, bringing the death toll to 1,30,519, according to the Health Ministry.
The number of daily cases has been declining for six consecutive weeks, and Monday’s figure of 30,548 was a “record low,” the Health Ministry said. A tweet from the official ministry administrator featured a chart of the number of daily cases from August to November 16, showing that cases increase until mid-September and then decline.
The single-day peak in coronavirus cases was reported on September 17 with 97,984 new cases of Covid-19 and since then India has witnessed a decline in the number of cases.
Additionally, the trend of daily Covid-19 recoveries exceeding daily infections continued for the 44th day on Monday, when the country recorded 30,548 cases of the infection. The number of recovered patients stood at 43,851.
Meanwhile, the Center has formed multidisciplinary teams to visit all private hospitals in Delhi to check the status of compliance with various instructions issued by the Union Ministry of Health for testing and treating Covid-19 patients.
The teams have been asked to begin their visit immediately and submit reports within two days along with specific details, according to the Union Interior Ministry. The Center has devised a strategy to control the spread of the disease in the national capital, which has seen an alarming increase in the number of daily cases of Covid-19.
There’s more good news on the vaccine front, as US-based biotech firm Moderna Inc said Monday that its vaccine candidate has been found to be 94.5 percent effective at preventing. of Covid-19. The announcement was based on phase 3 trials.
This comes just a week after Pfizer Inc and BioNTech SE announced that their vaccine candidate was more than 90% effective in preventing coronavirus disease.